Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy
Authors
Keywords
-
Journal
Acta Pharmaceutica Sinica B
Volume 12, Issue 12, Pages 4327-4347
Publisher
Elsevier BV
Online
2022-11-04
DOI
10.1016/j.apsb.2022.11.001
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments
- (2022) Shogo Kumagai et al. CANCER CELL
- The impact of protein corona on the biological behavior of targeting nanomedicines
- (2022) Masoud Farshbaf et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Combination strategies with PD-1/PD-L1 blockade: current advances and future directions
- (2022) Ming Yi et al. Molecular Cancer
- A BRD4 PROTAC nanodrug for glioma therapy via the intervention of tumor cells proliferation, apoptosis and M2 macrophages polarization
- (2022) Tingting Yang et al. Acta Pharmaceutica Sinica B
- Metabolic Reprogramming by Dual-targeting Biomimetic Nanoparticles for Enhanced Tumor Chemo-Immunotherapy
- (2022) Shuya Zang et al. Acta Biomaterialia
- Restoration of the Immunogenicity of Tumor Cells for Enhanced Cancer Therapy via Nanoparticle‐Mediated Copper Chaperone Inhibition
- (2022) Feixiang Ding et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- ATP-exhausted nanocomplexes for intratumoral metabolic intervention and photoimmunotherapy
- (2022) Mian Yu et al. BIOMATERIALS
- Cancer Immunoediting in the Era of Immuno-oncology
- (2022) Matthew M. Gubin et al. CLINICAL CANCER RESEARCH
- When artificial intelligence meets PD-1/PD-L1 inhibitors: Population screening, response prediction and efficacy evaluation
- (2022) Weiqiu Jin et al. COMPUTERS IN BIOLOGY AND MEDICINE
- PD-L1 siRNA–hyaluronic acid conjugate for dual-targeted cancer immunotherapy
- (2022) Suyeon Kim et al. JOURNAL OF CONTROLLED RELEASE
- Tumor-associated macrophages of the M1/M2 phenotype are involved in the regulation of malignant biological behavior of breast cancer cells through the EMT pathway
- (2022) Zhuo Chen et al. MEDICAL ONCOLOGY
- Copper induces cell death by targeting lipoylated TCA cycle proteins
- (2022) Peter Tsvetkov et al. SCIENCE
- Reversing insufficient photothermal therapy-induced tumor relapse and metastasis by regulating cancer-associated fibroblasts
- (2022) Xin Li et al. Nature Communications
- Copackaging photosensitizer and PD-L1 siRNA in a nucleic acid nanogel for synergistic cancer photoimmunotherapy
- (2022) Yuanyuan Guo et al. Science Advances
- Nano-delivery of salvianolic acid B induces the quiescence of tumor-associated fibroblasts via interfering with TGF-β1/Smad signaling to facilitate chemo- and immunotherapy in desmoplastic tumor
- (2022) Yunna Chen et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Delivery of an ectonucleotidase inhibitor with ROS-responsive nanoparticles overcomes adenosine-mediated cancer immunosuppression
- (2022) Chengqiong Mao et al. Science Translational Medicine
- Toll-like receptor (TLR) agonists as a driving force behind next-generation vaccine adjuvants and cancer therapeutics
- (2022) Arshpreet Kaur et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Myeloid derived suppressor cells and innate immune system interaction in tumor microenvironment
- (2022) Anik Pramanik et al. LIFE SCIENCES
- MHC Class I Loss in Triple-negative Breast Cancer
- (2021) Anna C. Dusenbery et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Critical immunosuppressive effect of MDSC‑derived exosomes in the tumor microenvironment
- (2021) Mohammad Rashid et al. ONCOLOGY REPORTS
- The reversed intra- and extracellular pH in tumors as a unified strategy to chemotherapeutic delivery using targeted nanocarriers
- (2021) Edgar Pérez-Herrero et al. Acta Pharmaceutica Sinica B
- Nanomedicine‐Boosting Tumor Immunogenicity for Enhanced Immunotherapy
- (2021) Jing Huang et al. ADVANCED FUNCTIONAL MATERIALS
- Shape Transformable Strategies for Drug Delivery
- (2021) Wenfeng Jia et al. ADVANCED FUNCTIONAL MATERIALS
- Phototherapy and anti-GITR antibody-based therapy synergistically reinvigorate immunogenic cell death and reject established cancers
- (2021) Qi Sun et al. BIOMATERIALS
- Immunomodulating nano-adaptors potentiate antibody-based cancer immunotherapy
- (2021) Cheng-Tao Jiang et al. Nature Communications
- Immune Checkpoint Inhibitor‐Based Strategies for Synergistic Cancer Therapy
- (2021) Mengying He et al. Advanced Healthcare Materials
- Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation
- (2021) Karthik Dhatchinamoorthy et al. Frontiers in Immunology
- Effect of physicochemical properties on in vivo fate of nanoparticle-based cancer immunotherapies
- (2021) Yongchao Wang et al. Acta Pharmaceutica Sinica B
- Recent Advances in Cancer Immunotherapy
- (2021) Kenichi Suda Biomolecules
- Engineering oxygen-deficient ZrO2-x nanoplatform as therapy-activated “immunogenic cell death (ICD)” inducer to synergize photothermal-augmented sonodynamic tumor elimination in NIR-II biological window
- (2021) Xiaodan Jiao et al. BIOMATERIALS
- MDSC: Markers, development, states, and unaddressed complexity
- (2021) Samarth Hegde et al. IMMUNITY
- Enhancing Cancer Immunotherapy Treatment Goals by Using Nanoparticle Delivery System
- (2021) Tobias Achu Muluh et al. International Journal of Nanomedicine
- Tubeimoside-1 induces TFEB-dependent lysosomal degradation of PD-L1 and promotes antitumor immunity by targeting mTOR
- (2021) Xiaojia Liu et al. Acta Pharmaceutica Sinica B
- Self-propelled nanomotor reconstructs tumor microenvironment through synergistic hypoxia alleviation and glycolysis inhibition for promoted anti-metastasis
- (2021) Wenqi Yu et al. Acta Pharmaceutica Sinica B
- Influencing factors and strategies of enhancing nanoparticles into tumors in vivo
- (2021) Mingming Zhang et al. Acta Pharmaceutica Sinica B
- Self-assembled FeS-based cascade bioreactor with enhanced tumor penetration and synergistic treatments to trigger robust cancer immunotherapy
- (2021) Hao Ren et al. Acta Pharmaceutica Sinica B
- Furin-instructed aggregated gold nanoparticles for re-educating tumor associated macrophages and overcoming breast cancer chemoresistance
- (2021) Rou Xie et al. BIOMATERIALS
- Reappraisal of anticancer nanomedicine design criteria in three types of preclinical cancer models for better clinical translation
- (2021) Xin Luan et al. BIOMATERIALS
- Tumor-Associated Macrophages as Multifaceted Regulators of Breast Tumor Growth
- (2021) Maliha Tabassum Munir et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting monoamine oxidase A-regulated tumor-associated macrophage polarization for cancer immunotherapy
- (2021) Yu-Chen Wang et al. Nature Communications
- Fucoidan-functionalized activated platelet-hitchhiking micelles simultaneously track tumor cells and remodel the immunosuppressive microenvironment for efficient metastatic cancer treatment
- (2021) Rong Guo et al. Acta Pharmaceutica Sinica B
- D-MT prompts the anti-tumor effect of oxaliplatin by inhibiting IDO expression in a mouse model of colon cancer
- (2021) Yongxi Zhang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways
- (2021) Lukas Kraehenbuehl et al. Nature Reviews Clinical Oncology
- Durvalumab: A Review in Extensive-Stage SCLC
- (2021) Zaina T. Al-Salama Targeted Oncology
- Siglec Signaling in the Tumor Microenvironment
- (2021) Eline J. H. van Houtum et al. Frontiers in Immunology
- Bioresponsive immune-booster-based prodrug nanogel for cancer immunotherapy
- (2021) Xianbin Ma et al. Acta Pharmaceutica Sinica B
- Co-delivery of photosensitizer and diclofenac through sequentially responsive bilirubin nanocarriers for combating hypoxic tumors
- (2021) Yang Zhou et al. Acta Pharmaceutica Sinica B
- Remodeling “cold” tumor immune microenvironment via epigenetic-based therapy using targeted liposomes with in situ formed albumin corona
- (2021) Yang He et al. Acta Pharmaceutica Sinica B
- Ca2+-Mediated Surface Polydopamine Engineering to Program Dendritic Cell Maturation
- (2020) Yiqiong Liu et al. ACS Applied Materials & Interfaces
- Tumor microenvironment-responsive prodrug nanoplatform via co-self-assembly of photothermal agent and IDO inhibitor for enhanced tumor penetration and cancer immunotherapy
- (2020) Yijia Liu et al. BIOMATERIALS
- Rationally Designed Polymer Conjugate for Tumor-Specific Amplification of Oxidative Stress and Boosting Antitumor Immunity
- (2020) Sheng Ma et al. NANO LETTERS
- Sialoglycans and Siglecs Can Shape the Tumor Immune Microenvironment
- (2020) Stephanie van de Wall et al. TRENDS IN IMMUNOLOGY
- Impaired death receptor signaling in leukemia causes antigen-independent resistance by inducing CAR T cell dysfunction
- (2020) Nathan Singh et al. Cancer Discovery
- Checkpoint molecules coordinately restrain hyperactivated effector T cells in the tumor microenvironment
- (2020) Min Yang et al. OncoImmunology
- Photothermal Depletion of Cancer-Associated Fibroblasts Normalizes Tumor Stiffness in Desmoplastic Cholangiocarcinoma
- (2020) Alba Nicolás-Boluda et al. ACS Nano
- Reprogramming Tumor Microenvironment with Photothermal Therapy
- (2020) Qinglian Hu et al. BIOCONJUGATE CHEMISTRY
- Macrophage-mimic shape changeable nanomedicine retained in tumor for multimodal therapy of breast cancer
- (2020) Rui Liu et al. JOURNAL OF CONTROLLED RELEASE
- EMA Review of Axicabtagene Ciloleucel (Yescarta) for the Treatment of Diffuse Large B‐Cell Lymphoma
- (2020) Irene Papadouli et al. ONCOLOGIST
- The role of tumor-associated macrophages (TAMs) in tumor progression and relevant advance in targeted therapy
- (2020) Qiyao Yang et al. Acta Pharmaceutica Sinica B
- Computed tomography and photoacoustic imaging guided photodynamic therapy against breast cancer based on mesoporous platinum with in-situ oxygen generation ability
- (2020) Lingyan Zhang et al. Acta Pharmaceutica Sinica B
- Nanomedicine-based drug delivery towards tumor biological and immunological microenvironment
- (2020) Jin Li et al. Acta Pharmaceutica Sinica B
- Loss of MHC Class I Expression in HPV-associated Cervical and Vulvar Neoplasia
- (2020) Megan E. Dibbern et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
- (2020) Yuanyuan Zhang et al. Cellular & Molecular Immunology
- Combined hybrid structure of siRNA tailed IVT mRNA (ChriST mRNA) for enhancing DC maturation and subsequent anticancer T cell immunity
- (2020) Kyuri Lee et al. JOURNAL OF CONTROLLED RELEASE
- Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors
- (2020) Lorenzo Galluzzi et al. Nature Reviews Clinical Oncology
- Stimuli-responsive prodrug-based cancer nanomedicine
- (2020) Angel Xie et al. EBioMedicine
- The progress and perspective of nanoparticle-enabled tumor metastasis treatment
- (2020) Wei Zhang et al. Acta Pharmaceutica Sinica B
- Dual-targeting nanovesicles enhance specificity to dynamic tumor cells in vitro and in vivo via manipulation of αvβ3-ligand binding
- (2020) Yang Song et al. Acta Pharmaceutica Sinica B
- Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors
- (2020) Qingyang Lei et al. Frontiers in Cell and Developmental Biology
- What Went Wrong with Anticancer Nanomedicine Design and How to Make It Right
- (2020) Duxin Sun et al. ACS Nano
- Phagocyte-membrane-coated and laser-responsive nanoparticles control primary and metastatic cancer by inducing anti-tumor immunity
- (2020) Chuan Hu et al. BIOMATERIALS
- IDO-inhibitor potentiated immunogenic chemotherapy abolishes primary tumor growth and eradicates metastatic lesions by targeting distinct compartments within tumor microenvironment
- (2020) Qilin Li et al. BIOMATERIALS
- Developing neobavaisoflavone nanoemulsion suppresses lung cancer progression by regulating tumor microenvironment
- (2020) Hui Ye et al. BIOMEDICINE & PHARMACOTHERAPY
- Erythrocyte-derived drug delivery systems in cancer therapy
- (2020) Yishen Mao et al. CHINESE CHEMICAL LETTERS
- Unconventional Peptide Presentation by Classical MHC Class I and Implications for T and NK Cell Activation
- (2020) Dirk M. Zajonc INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MHC class I loss in endometrial carcinoma: a potential resistance mechanism to immune checkpoint inhibition
- (2020) Lisa A. Friedman et al. MODERN PATHOLOGY
- Targeting STAT3 in Cancer Immunotherapy
- (2020) Sailan Zou et al. Molecular Cancer
- Anti-angiogenic Agents in Combination With Immune Checkpoint Inhibitors: A Promising Strategy for Cancer Treatment
- (2020) Yuxiao Song et al. Frontiers in Immunology
- A tumor-to-lymph procedure navigated versatile gel system for combinatorial therapy against tumor recurrence and metastasis
- (2020) Lin Qin et al. Science Advances
- GSH-responsive SN38 dimer-loaded shape-transformable nanoparticles with iRGD for enhancing chemo-photodynamic therapy
- (2020) Congcong Lin et al. Acta Pharmaceutica Sinica B
- Photothermal/matrix metalloproteinase-2 dual-responsive gelatin nanoparticles for breast cancer treatment
- (2020) Xiaojie Chen et al. Acta Pharmaceutica Sinica B
- Nanomedicines modulating tumor immunosuppressive cells to enhance cancer immunotherapy
- (2020) Yuefei Zhu et al. Acta Pharmaceutica Sinica B
- Manipulation of immune‒vascular crosstalk: new strategies towards cancer treatment
- (2020) Yang Zhao et al. Acta Pharmaceutica Sinica B
- Cancer Metabolism: Phenotype, Signaling and Therapeutic Targets
- (2020) Jae Hyung Park et al. Cells
- New emerging targets in cancer immunotherapy: the role of GITR
- (2020) Giulia Buzzatti et al. ESMO Open
- Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance
- (2020) Sreya Bagchi et al. Annual Review of Pathology-Mechanisms of Disease
- Discovery of VEGFR-2 inhibitors exerting significant anticancer activity against CD44+ and CD133+ cancer stem cells (CSCs): Reversal of TGF-β induced epithelial-mesenchymal transition (EMT) in hepatocellular carcinoma
- (2020) Siddharth J. Modi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Tumor-associated macrophage, angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients
- (2020) Ilseon Hwang et al. Journal of Translational Medicine
- Targeting immunogenic cell death in cancer
- (2020) Asma Ahmed et al. Molecular Oncology
- Immune checkpoints in targeted-immunotherapy of pancreatic cancer: New hope for clinical development
- (2020) Seyed Hossein Kiaie et al. Acta Pharmaceutica Sinica B
- The progress and perspective of strategies to improve tumor penetration of nanomedicines
- (2020) Jiang Hu et al. CHINESE CHEMICAL LETTERS
- CAR-T cells: Early successes in blood cancer and challenges in solid tumors
- (2020) Hassan Dana et al. Acta Pharmaceutica Sinica B
- Delivery technologies for cancer immunotherapy
- (2019) Rachel S. Riley et al. NATURE REVIEWS DRUG DISCOVERY
- Carbon-dot-supported atomically dispersed gold as a mitochondrial oxidative stress amplifier for cancer treatment
- (2019) Ningqiang Gong et al. Nature Nanotechnology
- Discovery of potent indoleamine 2,3-dioxygenase (IDO) inhibitor from alkaloids in Picrasma quassioides by virtual screening and in vitro evaluation
- (2019) Ning Wang et al. FITOTERAPIA
- VEGF in Signaling and Disease: Beyond Discovery and Development
- (2019) Rajendra S. Apte et al. CELL
- Hypoxia alleviation-triggered enhanced photodynamic therapy in combination with IDO inhibitor for preferable cancer therapy
- (2019) Lei Xing et al. BIOMATERIALS
- The role of PD-1/PD-L1 axis and macrophage in the progression and treatment of cancer
- (2019) Jiajing Cai et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Tumor Microenvironment‐Responsive Dual Drug Dimer‐Loaded PEGylated Bilirubin Nanoparticles for Improved Drug Delivery and Enhanced Immune‐Chemotherapy of Breast Cancer
- (2019) Xiaotong Yang et al. ADVANCED FUNCTIONAL MATERIALS
- Understanding and overcoming the resistance of cancer to PD-1/PD-L1 blockade
- (2019) Amy L. Shergold et al. PHARMACOLOGICAL RESEARCH
- Cdk5 knocking out mediated by CRISPR-Cas9 genome editing for PD-L1 attenuation and enhanced antitumor immunity
- (2019) Huan Deng et al. Acta Pharmaceutica Sinica B
- Reshaping Prostate Tumor Microenvironment To Suppress Metastasis via Cancer-Associated Fibroblast Inactivation with Peptide-Assembly-Based Nanosystem
- (2019) Jiayan Lang et al. ACS Nano
- The sialoglycan-Siglec glyco-immune checkpoint – a target for improving innate and adaptive anti-cancer immunity
- (2019) Anne Bärenwaldt et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- The Dark Side of Fibroblasts: Cancer-Associated Fibroblasts as Mediators of Immunosuppression in the Tumor Microenvironment
- (2019) Lea Monteran et al. Frontiers in Immunology
- Sequentially responsive biomimetic nanoparticles with optimal size in combination with checkpoint blockade for cascade synergetic treatment of breast cancer and lung metastasis
- (2019) Wenqi Yu et al. BIOMATERIALS
- Anti-VEGF/VEGFR2 monoclonal antibodies and their combinations with PD-1/PD-L1 inhibitors in clinic
- (2019) Feng Gao et al. CURRENT CANCER DRUG TARGETS
- Aggregable Nanoparticles-Enabled Chemotherapy and Autophagy Inhibition Combined with Anti-PD-L1 Antibody for Improved Glioma Treatment
- (2019) Shaobo Ruan et al. NANO LETTERS
- The European Medicines Agency Review of Kymriah (Tisagenlecleucel) for the Treatment of Acute Lymphoblastic Leukemia and Diffuse Large B‐Cell Lymphoma
- (2019) Sahra Ali et al. ONCOLOGIST
- Ginseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth
- (2019) Meng Cao et al. Journal for ImmunoTherapy of Cancer
- Breast Cancer Cells and PD-1/PD-L1 Blockade Upregulate the Expression of PD-1, CTLA-4, TIM-3 and LAG-3 Immune Checkpoints in CD4+ T Cells
- (2019) Saleh et al. Vaccines
- Crucial players in glycolysis: Cancer progress
- (2019) Zaka Abbaszadeh et al. GENE
- Self-Delivery Micellar Nanoparticles Prevent Premetastatic Niche Formation by Interfering with the Early Recruitment and Vascular Destruction of Granulocytic Myeloid-Derived Suppressor Cells
- (2019) Yang Long et al. NANO LETTERS
- Preserving the CTLA-4 Checkpoint for Safer and More Effective Cancer Immunotherapy
- (2019) Yang Liu et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- A hispanolone-derived diterpenoid inhibits M2-Macrophage polarization in vitro via JAK/STAT and attenuates chitin induced inflammation in vivo
- (2018) Lidia Jiménez-García et al. BIOCHEMICAL PHARMACOLOGY
- Immuno-modulators enhance antigen-specific immunity and anti-tumor effects of mesothelin-specific chimeric DNA vaccine through promoting DC maturation
- (2018) Yu-Li Chen et al. CANCER LETTERS
- Evolving Roles for Targeting CTLA-4 in Cancer Immunotherapy
- (2018) Yinghao Zhao et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- The transition from HLA-I positive to HLA-I negative primary tumors: the road to escape from T-cell responses
- (2018) Natalia Aptsiauri et al. CURRENT OPINION IN IMMUNOLOGY
- Targeting the tumour stroma to improve cancer therapy
- (2018) Kenneth C. Valkenburg et al. Nature Reviews Clinical Oncology
- Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
- (2018) Dai Fukumura et al. Nature Reviews Clinical Oncology
- Combination antitumor immunotherapy with VEGF and PIGF siRNA via systemic delivery of multi-functionalized nanoparticles to tumor-associated macrophages and breast cancer cells
- (2018) Yudong Song et al. BIOMATERIALS
- Paclitaxel reduces tumor growth by reprogramming tumor-associated macrophages to an M1- profile in a TLR4-dependent manner
- (2018) Carlos W Wanderley et al. CANCER RESEARCH
- Nanoparticle-Mediated Remodeling of the Tumor Microenvironment to Enhance Immunotherapy
- (2018) Sara Musetti et al. ACS Nano
- The impact of protein corona on the behavior and targeting capability of nanoparticle-based delivery system
- (2018) Wei Xiao et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- HIP1R targets PD-L1 to lysosomal degradation to alter T cell–mediated cytotoxicity
- (2018) Huanbin Wang et al. Nature Chemical Biology
- Turning foes to friends: targeting cancer-associated fibroblasts
- (2018) Xueman Chen et al. NATURE REVIEWS DRUG DISCOVERY
- Repolarization of myeloid derived suppressor cells via magnetic nanoparticles to promote radiotherapy for glioma treatment
- (2018) Congyu Wu et al. Nanomedicine-Nanotechnology Biology and Medicine
- Co-delivery of RNAi and chemokine by polyarginine nanocapsules enables the modulation of myeloid-derived suppressor cells
- (2018) Adriana M. Ledo et al. JOURNAL OF CONTROLLED RELEASE
- Nanomedicine Strategies to Target Tumor-Associated Macrophages
- (2017) Karin Binnemars-Postma et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Protein corona: a new approach for nanomedicine design
- (2017) Van Hong Nguyen et al. International Journal of Nanomedicine
- Spatio-temporal control strategy of drug delivery systems based nano structures
- (2017) Nahla Rahoui et al. JOURNAL OF CONTROLLED RELEASE
- PD-1 checkpoint inhibition: Toxicities and management
- (2017) Andrew W. Hahn et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- BIX02189 inhibits TGF-β1-induced lung cancer cell metastasis by directly targeting TGF-β type I receptor
- (2016) Seong Ji Park et al. CANCER LETTERS
- The Emerging Hallmarks of Cancer Metabolism
- (2016) Natalya N. Pavlova et al. Cell Metabolism
- Regulatory T cells in cancer immunotherapy
- (2016) Atsushi Tanaka et al. CELL RESEARCH
- Calreticulin acts as an adjuvant to promote dendritic cell maturation and enhances antigen-specific cytotoxic T lymphocyte responses against non-small cell lung cancer cells
- (2016) Xinli Liu et al. CELLULAR IMMUNOLOGY
- TGF-β Signaling in Cancer
- (2016) Viqar Syed JOURNAL OF CELLULAR BIOCHEMISTRY
- To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?
- (2016) F. Danhier JOURNAL OF CONTROLLED RELEASE
- IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance
- (2016) David H. Munn et al. TRENDS IN IMMUNOLOGY
- Differential expression of major histocompatibility complex class I in subtypes of breast cancer is associated with estrogen receptor and interferon signaling
- (2016) Hee Jin Lee et al. Oncotarget
- Blocking of the PD-1/PD-L1 Interaction by aD-Peptide Antagonist for Cancer Immunotherapy
- (2015) Hao-Nan Chang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies
- (2015) J. Naidoo et al. ANNALS OF ONCOLOGY
- Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
- (2015) Edgar Pérez-Herrero et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- From mice to humans: developments in cancer immunoediting
- (2015) Michele W.L. Teng et al. JOURNAL OF CLINICAL INVESTIGATION
- The Multifaceted Role of Curcumin in Cancer Prevention and Treatment
- (2015) Muthu Shanmugam et al. MOLECULES
- Targeting CCR4 as an emerging strategy for cancer therapy and vaccines
- (2014) Jagadeesh Bayry et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Tumor-Associated Macrophages as Major Players in the Tumor Microenvironment
- (2014) Theerawut Chanmee et al. Cancers
- Altered Tumor-Cell Glycosylation Promotes Metastasis
- (2014) Irina Häuselmann et al. Frontiers in Oncology
- Nanomedicine therapeutic approaches to overcome cancer drug resistance
- (2013) Janet L. Markman et al. ADVANCED DRUG DELIVERY REVIEWS
- Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy
- (2013) Matthew D. Vesely et al. Annals of the New York Academy of Sciences
- Cytokine patterns in patients with cancer: a systematic review
- (2013) Bodo E Lippitz LANCET ONCOLOGY
- New Aspects of an Old Drug – Diclofenac Targets MYC and Glucose Metabolism in Tumor Cells
- (2013) Eva Gottfried et al. PLoS One
- The stimulatory effect of TLRs ligands on maturation of chicken bone marrow-derived dendritic cells
- (2013) Jinfeng Liang et al. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
- VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2
- (2012) N G Gavalas et al. BRITISH JOURNAL OF CANCER
- Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2
- (2012) Tadashi Yokosuka et al. JOURNAL OF EXPERIMENTAL MEDICINE
- What are regulatory T cells (Treg) regulating in cancer and why?
- (2012) Theresa L. Whiteside SEMINARS IN CANCER BIOLOGY
- Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape
- (2011) S.-R. Woo et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- From Tumor Immunosuppression to Eradication: Targeting Homing and Activity of Immune Effector Cells to Tumors
- (2011) Oana Draghiciu et al. Clinical & Developmental Immunology
- Tumor Immune Escape Mechanisms that Operate During Metastasis
- (2011) D. O. Croci et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Cell-mediated drug delivery
- (2011) Elena V Batrakova et al. Expert Opinion on Drug Delivery
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Drug delivery and nanoparticles: Applications and hazards
- (2010) de Jong International Journal of Nanomedicine
- Glycan changes: cancer metastasis and anti-cancer vaccines
- (2010) Min Li et al. JOURNAL OF BIOSCIENCES
- TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progression
- (2010) Li Yang et al. TRENDS IN IMMUNOLOGY
- TGF-β-induced epithelial to mesenchymal transition
- (2009) Jian Xu et al. CELL RESEARCH
- VEGF induces expression of Bcl-2 and multiple signaling factors in microvascular endothelial cells in a prostate cancer model
- (2009) Yoshihisa Sakai et al. WORLD JOURNAL OF UROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started